| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer | VP, Clinical Development
2 companies
Yu K Peony is a Chief Medical Officer at FIBROGEN INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 7,500 | $41.03 | $307,725.00 | -3.8% | |
| Aug 8, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sale+OE | 37,500 | $50.58 | $1,896,861.00 | -8.5% | |
| Aug 1, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sale+OE | 10,000 | $33.48 | $334,800.00 | -4.4% | |
| Jul 10, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 5,000 | $32.98 | $164,900.00 | -2.3% | |
| Jun 14, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 3,721 | $28.95 | $107,722.95 | -1.7% | |
| May 10, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 5,000 | $26.38 | $131,890.00 | -1.1% | |
| Apr 25, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sale+OE | 5,000 | $28.00 | $140,000.00 | -2.1% | |
| Mar 14, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 7,851 | $25.41 | $199,458.23 | -1.7% | |
| Jan 10, 2017 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 5,000 | $23.56 | $117,800.00 | -2.4% | |
| Dec 14, 2016 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 2,344 | $20.65 | $48,403.60 | -1.1% |